glp 1 and visceral fat How GLP-1 Medications Reduce Heart Disease Risk 💉📊 Weight loss is more

Regular follow-up with your GP or specialist diabetes team should include: HbA1c monitoring (typically every 3-6 months initially, then 6-12 monthly when stable) [9] [26] Weight and cardiovascular risk factor tracking Medication adjustment as needed Early identification of complications Psychological support for behaviour change When to seek medical advice : Contact your GP if you experience unexplained weight regain, worsening diabetes symptoms (increased thirst, urination, fatigue), or wish to discuss treatment modifications

As with semaglutide and tirzepatide, some patients will be high responders and others will experience more modest effects

doi: 10.1089/ast.2006.6.463, 42 HanR.ZhangX.LiuJ.LongQ.ChenL.LiuD.et al

V., Freitas, B

McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J (2016) Health-related quality of life measured using the EQ-5D-5L: South Australian population norms